AZD6234
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel
AstraZeneca · Phase 1 · Active, not recruiting · Enrollment 100
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cohort-1: AZD6234 + EE/LEVO + Acetaminophen (APAP) | Healthy Participants | n/r | n/r | n/r | n/r |
| Cohort-2: AZD6234+AZD9550+EE/LEVO+APAP | Healthy Participants | n/r | n/r | n/r | n/r |
| Cohort-3: AZD9550 + EE/LEVO + APAP | Healthy Participants | n/r | n/r | n/r | n/r |
| Cohort-4: AZD6234+AZD9550+EE/LEVO+APAP | Healthy Participants | n/r | n/r | n/r | n/r |